News

Simulations Plus (SLP) AI-Driven Drug Design Collaboration Yields Positive Results
Simulations Plus, Inc. (NASDAQ:SLP) is one of the top 10 medical AI companies to buy according to analysts. On July 29, the ...
Colorectal cancer study expands and optimizes 3D tumor models
Researchers from the Germans Trias i Pujol Research Institute (IGTP) have published a study in Scientific Reports that ...
EurekAlert!1d
New study expands and optimizes 3D models to investigate colorectal cancer
Researchers from the Cancer Genetics and Epigenetics group at IGTP have published a study in Scientific Reports presenting a ...
Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling
Certara, Inc., a global leader in biosimulation, today announced that the European Medicines Agency (EMA) has formally qualified the Simcyp® Simulator for use in regulatory submissions across the EU.
Devdiscourse2d
From Code to Cure: Generative AI’s Role in Drug Discovery and Protein Engineering
This review explores how generative AI, through models like VAEs, GANs, transformers, and diffusion networks is ...
Simulations of beating heart may inform treatments for atrial fibrillation
You may have heard the phrase "my heart skipped a beat" when someone was talking about a romantic encounter. In truth, hearts ...